Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
0.3170
+0.0074 (2.39%)
Apr 1, 2025, 10:34 AM EDT - Market open
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $10.64 million as of April 1, 2025. Its market cap has decreased by -71.39% in one year.
Market Cap
10.64M
Enterprise Value
-16.58M
1-Year Change
-71.39%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $69.28M to $10.64M, a decrease of -84.64%. That is a compound annual growth rate of -21.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.17B |
| UnitedHealth Group | 481.31B |
| Johnson & Johnson | 399.77B |
| AbbVie | 369.19B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 229.57B |
| Merck & Co. | 226.08B |
| AstraZeneca | 225.46B |